Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
EVMN
EVMN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest EVMN ETF News Today | Earnings, Events & Price Alerts
EVMN News
Benzinga Stock Whisper Index Analysis
Feb 15 2026
Benzinga
Evommune Secures $125M in Private Placement Agreement
Feb 13 2026
seekingalpha
Evommune Enters Private Placement Agreement for $125 Million
Feb 13 2026
Businesswire
Evommune Secures $125 Million in Private Placement
Feb 13 2026
Newsfilter
Evommune Shares Drop on Profit-Taking After 70% Surge
Feb 12 2026
Benzinga
EVO301 Clinical Trial Achieves Significant Results
Feb 10 2026
Benzinga
Datadog Beats Earnings Estimates, Shares Surge 16.3%
Feb 10 2026
Benzinga
Evommune Shares Surge Over 50% After Mid-Stage Trial Success for EVO301
Feb 10 2026
seekingalpha
U.S. Stocks Mixed in Morning Trading
Feb 10 2026
Benzinga
Evommune's Atopic Dermatitis Drug Trial Success Boosts Shares
Feb 10 2026
stocktwits
EVO301 Clinical Trial Achieves Positive Results
Feb 10 2026
Newsfilter
Aktis Oncology Launches $200 Million IPO with $100 Million Investment from Eli Lilly
Jan 09 2026
renaissancecapital
Analysts Adjust Ratings on Wealthfront and Spire Global with Price Targets
Jan 06 2026
Benzinga
Aktis Oncology Files for IPO in the U.S. Targeting $346 Million in Funding
Dec 19 2025
Newsfilter
Carnival Reports Robust Q4 Earnings, Alongside Amicus Therapeutics, Biomarin Pharmaceutical, and Other Major Stocks Rising on Friday
Dec 19 2025
Benzinga
Evommune Raises $172.5M in IPO to Advance Key Clinical Trials
Dec 11 2025
Newsfilter
Show More News
